MedPath

The effect of gel containing Prunella vulgaris extract on labial herpes

Phase 2
Conditions
recurrent herpes labialis.
Herpesviral vesicular dermatitis
Registration Number
IRCT2016021412438N16
Lead Sponsor
Barij Research Center of Medicinal Herbs
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Inclusion: People 18 to 70 years old with recurrent herpes labialis that Less than 12 hours have passed vesicate.
Exclusion criteria: Pregnancy and lactatin; use the antiviral drug in the past two weeks; have a history of immunotherapy in the last year; stimulating the immune system in the last month; Other mucocutaneous disorders; history of RAS ;history of allergy to the plant used in the study of allergic reaction during the study

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical symptoms of blisters. Timepoint: Baseline and End-of-trial. Method of measurement: Observation.;Burning. Timepoint: At days 0, 2, 4, 7. Method of measurement: VAS.;Iitching. Timepoint: At days 0, 2, 4, 7. Method of measurement: VAS.;Soreness. Timepoint: At days 0, 2, 4, 7. Method of measurement: VAS.;Tingling. Timepoint: At days 0,2,4,7. Method of measurement: VAS.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath